GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shoppers Drug Mart Corporation (FRA:SDZ) » Definitions » Beneish M-Score

Shoppers Drug Mart (FRA:SDZ) Beneish M-Score : 0.00 (As of Jun. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Shoppers Drug Mart Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Shoppers Drug Mart's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Shoppers Drug Mart was 0.00. The lowest was 0.00. And the median was 0.00.


Shoppers Drug Mart Beneish M-Score Historical Data

The historical data trend for Shoppers Drug Mart's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shoppers Drug Mart Beneish M-Score Chart

Shoppers Drug Mart Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -2.41 -2.62 -2.42

Shoppers Drug Mart Quarterly Data
Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.62 -2.63 -2.51 -2.36 -2.42

Competitive Comparison of Shoppers Drug Mart's Beneish M-Score

For the Pharmaceutical Retailers subindustry, Shoppers Drug Mart's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shoppers Drug Mart's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Shoppers Drug Mart's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Shoppers Drug Mart's Beneish M-Score falls into.



Shoppers Drug Mart Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Shoppers Drug Mart for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0722+0.528 * 1.0036+0.404 * 0.9944+0.892 * 0.956+0.115 * 0.9121
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0266+4.679 * -0.015093-0.327 * 0.9719
=-2.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec13) TTM:Last Year (Dec12) TTM:
Total Receivables was €371 Mil.
Revenue was 1884.716 + 2377.31 + 1865.559 + 1873.119 = €8,001 Mil.
Gross Profit was 732.929 + 910.281 + 720.555 + 721.308 = €3,085 Mil.
Total Current Assets was €2,022 Mil.
Total Assets was €5,232 Mil.
Property, Plant and Equipment(Net PPE) was €1,128 Mil.
Depreciation, Depletion and Amortization(DDA) was €235 Mil.
Selling, General, & Admin. Expense(SGA) was €1,572 Mil.
Total Current Liabilities was €1,417 Mil.
Long-Term Debt & Capital Lease Obligation was €340 Mil.
Net Income was 116.269 + 119.942 + 107.996 + 90.021 = €434 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = €0 Mil.
Cash Flow from Operations was 244.46 + 105.964 + 133.738 + 29.028 = €513 Mil.
Total Receivables was €362 Mil.
Revenue was 2095.208 + 2545.532 + 1904.655 + 1823.9 = €8,369 Mil.
Gross Profit was 815.694 + 976.959 + 746.284 + 699.902 = €3,239 Mil.
Total Current Assets was €2,129 Mil.
Total Assets was €5,752 Mil.
Property, Plant and Equipment(Net PPE) was €1,323 Mil.
Depreciation, Depletion and Amortization(DDA) was €247 Mil.
Selling, General, & Admin. Expense(SGA) was €1,602 Mil.
Total Current Liabilities was €1,798 Mil.
Long-Term Debt & Capital Lease Obligation was €190 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(370.614 / 8000.704) / (361.587 / 8369.295)
=0.046323 / 0.043204
=1.0722

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3238.839 / 8369.295) / (3085.073 / 8000.704)
=0.386991 / 0.3856
=1.0036

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2022.466 + 1128.27) / 5231.807) / (1 - (2128.64 + 1322.601) / 5752.164)
=0.397773 / 0.40001
=0.9944

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=8000.704 / 8369.295
=0.956

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(247.176 / (247.176 + 1322.601)) / (235.412 / (235.412 + 1128.27))
=0.157459 / 0.17263
=0.9121

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1571.751 / 8000.704) / (1601.573 / 8369.295)
=0.196452 / 0.191363
=1.0266

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((340.322 + 1416.794) / 5231.807) / ((190.16 + 1797.542) / 5752.164)
=0.335853 / 0.345557
=0.9719

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(434.228 - 0 - 513.19) / 5231.807
=-0.015093

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Shoppers Drug Mart has a M-score of -2.53 suggests that the company is unlikely to be a manipulator.


Shoppers Drug Mart Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Shoppers Drug Mart's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Shoppers Drug Mart (FRA:SDZ) Business Description

Traded in Other Exchanges
N/A
Address
Shoppers Drug Mart Corporation was founded in 1962. The Company is the licensor of full-service retail drug stores operating under the name Shoppers Drug Mart (Pharmaprix in Québec). The stores are owned and operated by the Company's licensed Associate-owners who have helped build a brand that is synonymous with exceptional service, value and trust. The Company also licenses or owns more than 55 medical clinic pharmacies operating under the name Shoppers Simply Pharmacy (Pharmaprix Simplement Santé in Québec) and six luxury beauty destinations operating as Murale. The Company owns and operates 62 Shoppers Home Health Care stores, which are engaged in the sale and service of assisted-living devices, medical equipment, home-care products and durable mobility equipment to institutional and retail customers. In addition to its retail store network, the Company owns Shoppers Drug Mart Specialty Health Network Inc., a provider of specialty drug distribution, pharmacy and comprehensive patient support services, and MediSystem Technologies Inc., a provider of pharmaceutical products and services to long-term care facilities.

Shoppers Drug Mart (FRA:SDZ) Headlines

No Headlines